Background illustration for clinical trials search

Regeneron Pharmaceuticals Clinical Trials

Find clinical trials for Regeneron Pharmaceuticals. Search for Regeneron Pharmaceuticals clinical trials in different cities and states across the United States.

Filter
Active & Responsive

A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations

for
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF),
Location: Boston MA, New York NY, Orlando FL, Jacksonville FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 0+

Code: NCT05788536

Phase 1, Phase 2, Recruiting
New

This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Mullica Hill NJ
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 40+

Code: NCT07587658

Phase 4, Recruiting
New

First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

for
Healthy Volunteer, Atopic Dermatitis
Location: Miami FL, North Charleston SC, Birmingham AL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07527923

Phase 1, Recruiting
New

REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension

for
Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT)
Location: Deerfield Beach FL
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07675824

Phase 1, Phase 2, Recruiting

A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

for
Paroxysmal Nocturnal Hemoglobinuria
Location: Toronto
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05744921

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

for
Relapsed Refractory Multiple Myeloma (RRMM)
Location: Durham NC
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05730036

Phase 3, Recruiting

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
Location: Boston MA, Stony Brook NY, New York NY, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06140524

Phase 2, Recruiting

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: New York NY, Tampa FL, Columbus OH, Atlanta GA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03761108

Phase 1, Phase 2, Recruiting

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

for
Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma,
Location: Boston MA, Hackensack NJ, Buffalo NY, Pittsburgh PA,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06469281

Phase 1, Recruiting

A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: New Haven CT, New Brunswick NJ, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT05125016

Phase 1, Phase 2, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Providence RI, New Haven CT, Lebanon NH, Quebec,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase 3, Recruiting

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Boston MA, New York NY, Philadelphia PA, Columbus OH,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT04590326

Phase 1, Phase 2, Recruiting

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

for
Cutaneous Squamous Cell Carcinoma (CSCC)
Location: Beverly MA, Portsmouth NH, Boston MA, New York NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06585410

Phase 3, Recruiting

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

for
Relapsed/Refractory Follicular Lymphoma,
Location: Lebanon NH, Stony Brook NY, Plantation FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06149286

Phase 3, Recruiting

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

for
Relapsed/Refractory Systemic Light Chain Amyloidosis
Location: Boston MA, Buffalo NY, Columbus OH, Detroit MI,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06292780

Phase 1, Phase 2, Recruiting

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

for
Melanoma, Clear-Cell Renal-Cell Carcinoma (ccRCC),
Location: North Haven CT, Lake Success NY, Chapel Hill NC,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06413680

Phase 1, Phase 2, Recruiting

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

for
Hemophilia B
Location: New Haven CT, Montreal, Philadelphia PA, Hamilton,
Sponsor: Regeneron Pharmaceuticals

Sex: Male

Age: 2+

Code: NCT06379789

Phase 1, Phase 2, Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

for
Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer,
Location: Boston MA, New York NY, Richmond VA, Columbus OH,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT03564340

Phase 1, Phase 2, Recruiting

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

for
B-cell Non-Hodgkins Lymphoma (B-NHL)
Location: Boston MA, New York NY, New Brunswick NJ, Louisville KY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05685173

Phase 1, Recruiting

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)

for
Amyotrophic Lateral Sclerosis (ALS),
Location: Montreal, Toronto, London, Edmonton
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06351592

Phase 1, Phase 2, Recruiting